KNSA (Kiniksa Pharmaceuticals, Ltd.) Net Profit
The growth of Kiniksa Pharmaceuticals (KNSA) is based on the development of therapies for rare autoimmune pathologies and the diversification of its R&D portfolio. The company's net income clearly confirms this success, while the 0.11 metric characterizes this valuation parameter. Monopoly status is ensured by patent protection of antibodies, while a high-demand drug for the treatment of pericarditis serves as a cash cow.
Analytical breakdowns and data insights for company Kiniksa (KNSA)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Kiniksa Pharmaceuticals|KNSA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Kiniksa Pharmaceuticals, Ltd.|KNSA - Company Total Debt|Debts to Book Capitalization Kiniksa Corp|KNSA - Company Long-Term Debt|Company Short-Term Indebtedness Kiniksa|Immediate Liquidity kiniksa.com
- net income and valuation multiples indicators:
Summary company analysis:Kiniksa Pharmaceuticals
This metric reflects the net cash balance after deducting all operating and financial expenses, demonstrating the actual efficiency of value generation amid shifting liquidity. An analysis of Kiniksa Pharmaceuticals (KNSA) cash profit allows for an assessment of business resilience, where stable revenue growth from the sale of the drug Inertia confirms the high commercial value of the therapy and minimizes the risks of capital drawdown.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Grifols Biemat (GRFS)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|PHAR - Company Net Income|NKTR - Net Profit|UPB: Net Profit|ZBIO - Net Financial Result|Company Net Income Immunome|Company Profit GOSS (Gossamer Bio Inc)|Net Profit KALV|Net Financial Result Septerna Pharma|Company Net Income Pieris Pharmaceuticals PVLA|Net Profit savarapharma.com SVRA|RIGL - Company Net Income|Net Financial Result AnaptysBio Inc ANAB|ATXS: Net Profit|enGene Corp (ENGN) - Net Profit|Net Income RAPT|JBIO: Final Profit|Company Net Income Aclaris Therapeutics, Inc. (ACRS)|KYTX: Profit After Tax|Net Profit TLSA (Tiziana Life Sciences PLC)|Final Profit CABA|Ventyx Biosciences - Net Profit|THTX - Net Profit|Avalo Therapeutics (AVTX) - Company Net Income|Eledon Pharmaceuticals Inc. - Final Profit|Company Net Income Agenus Inc|Net Income Climb Bio, Inc (CLYM)|Net Profit ZURA|Net Profit atyrpharma.com (ATYR)|Net Profit ADAG (Adagene Inc.)|IMA - Net Income|Shattuck Therapeutics - Net Profit|Company Net Income Equillium, Inc.|CNTB (connectbiopharm.com) - Net Income|Immunic (IMUX) - Net Profit|Net Income ATRA|IFRX (InflaRx GmbH) - Profit After Payment of Taxes|Net Profit XFOR|Net Financial Result adicetbio.com|Net Profit CELU (Celularity)|INMB - Net Income|Barinthus Biotherapeutics plc - Net Profit|KZR - Net Profit|SAB Biotherapeutics, Inc (SABS) - Company Net Income|AKTX (Akari Therapeutics, Plc) - Company Net Income|Company Net Income Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Net Financial Result|Company Net Income GeoVax (GOVX)|Net Profit Edesa Biotech Inc (EDSA)|Company Net Income iBio Corp IBIO|CARM: Company Profit|XTLB - Company Net Income|Net Financial Result Bolt Biotherapeutics BOLT|HCWB: Net Profit|Aptevo Therapeutics Inc. (APVO) - Net Profit|Company Net Income AIM ImmunoTech|Aditxt Corp - Profit After Tax|Net Profit GRI|XRTX (xortx.com) - Final Profit|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|INDP - Company Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|ALLK (Allakos Inc) - Net Profit|Net Profit HOOKIPA|Net Income IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Pharma) - Final Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|Net Financial Result tcbiopharm.com (TCBP)|THRD - Company Net Income